Clinical trial
Placebo Controlled Trial of Valproate and Risperidone in Young Children With…
NCT00221403 · Children's Hospital Medical Center, Cincinnati, Other · Completed
Key facts
| NCT number | NCT00221403 |
|---|---|
| Title | Placebo Controlled Trial of Valproate and Risperidone in Young Children With Bipolar Disorders |
| Official title | Placebo Controlled Trial of Valproate and Risperidone in Young Children With Bipolar Disorders |
| Lead sponsor | Children's Hospital Medical Center, Cincinnati, Other |
| Collaborators | Stanley Medical Research Institute |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bipolar Disorder |
| Intervention type | Drug, Other |
| Interventions | Risperidone oral solution, Valproate Oral Solution, Placebo |
| Enrollment | 46 |
| Start date | Sep 1, 2004 |
| Primary completion | May 1, 2011 |
| Completion | May 1, 2011 |
| First posted | Sep 22, 2005 |
| Last update posted | Oct 20, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: